Nessan Bermingham - Net Worth and Insider Trading
Nessan Bermingham Net Worth
The estimated net worth of Nessan Bermingham is at least $11 Million dollars as of 2024-06-06. Nessan Bermingham is the President & CEO of Intellia Therapeutics Inc and owns about 458,250 shares of Intellia Therapeutics Inc (NTLA) stock worth over $11 Million. Details can be seen in Nessan Bermingham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nessan Bermingham has not made any transactions after 2017-12-08 and currently still holds the listed stock(s).
Transaction Summary of Nessan Bermingham
Nessan Bermingham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nessan Bermingham owns 3 companies in total, including Intellia Therapeutics Inc (NTLA) , F-star Therapeutics Inc (FSTX) , and Korro Bio Inc (KRRO) .
Click here to see the complete history of Nessan Bermingham’s form 4 insider trades.
Insider Ownership Summary of Nessan Bermingham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2017-12-08 | director & 10 percent owner & President & CEO |
| FSTX | F-star Therapeutics Inc | 2023-03-08 | director |
| KRRO | Korro Bio Inc | 2023-11-03 | director |
Nessan Bermingham Latest Holdings Summary
Nessan Bermingham currently owns a total of 1 stock. Nessan Bermingham owns 458,250 shares of Intellia Therapeutics Inc (NTLA) as of December 8, 2017, with a value of $11 Million.
Latest Holdings of Nessan Bermingham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2017-12-08 | 458,250 | 23.09 | 10,580,993 |
Holding Weightings of Nessan Bermingham
Nessan Bermingham Form 4 Trading Tracker
According to the SEC Form 4 filings, Nessan Bermingham has made a total of 0 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years. The most-recent trade in Intellia Therapeutics Inc is the sale of 336,783 shares on December 8, 2017, which brought Nessan Bermingham around $7 Million.
Insider Trading History of Nessan Bermingham
- 1
Nessan Bermingham Trading Performance
Nessan Bermingham Ownership Network
Nessan Bermingham Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Nessan Bermingham is the director & 10 percent owner & President & CEO of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Business Officer Derek Hicks , and EVP & Chief Technical Officer Eliana Clark .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Nessan Bermingham made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .
In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Nessan Bermingham Mailing Address
Above is the net worth, insider trading, and ownership report for Nessan Bermingham. You might contact Nessan Bermingham via mailing address: 890 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
